Abstract
Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body1. A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely2,3, is released on neuron depolarization1, and triggers rapid intracellular signals4 and action potentials in central neurons5. Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine. Using lesions and gene-targeted mice lacking BDNF, we show that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D3 receptor in nucleus accumbens6,7,8 both during development and in adulthood. BDNF from corticostriatal neurons3 also induces behavioural sensitization, by triggering overexpression of the D3 receptor in striatum of hemiparkinsonian rats9. Our results suggest that BDNF may be an important determinant of pathophysiological conditions such as drug addiction10, schizophrenia11 or Parkinson's disease12, in which D3 receptor expression is abnormal.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thoenen, H. Neurotrophins and neuronal plasticity. Science 270, 593–598 (1995).
von Bartheld, C. S., Byers, M. R., Williams, R. & Bothwell, M. Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system. Nature 379, 830–833 (1996).
Altar, C. A. et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856–860 (1997).
Altar, C. A. & DiStefano, P. S. Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21, 433–437 (1998).
Kafitz, K. W., Rose, C. R., Thoenen, H. & Konnerth, A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401, 918–921 (1999).
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L. & Schwartz, J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146–151 (1990).
Diaz, J. et al. Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain. J. Neurosci. 17, 4282–4292 (1997).
Pilla, M. et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400, 371–375 (1999).
Bordet, R. et al. Induction of dopamine D3 receptor as a mechanism of behavioral sensitization to levodopa. Proc. Natl Acad. Sci. USA 94, 3363–3367 (1997).
Staley, J. K. & Mash, D. C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 16, 6100–6106 (1996).
Gurevich, E. V. et al. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. Arch. Gen. Psychiatry 54, 225–232 (1997).
Ryoo, H. L., Pierrotti, D. & Joyce, J. N. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Mov. Disord. 13, 788–797 (1998).
Lévesque, D. et al. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl Acad. Sci. USA 92, 1719–1723 (1995).
Seroogy, K. B. et al. Dopaminergic neurons in rat ventral midbrain express Brain-Derived Neurotrophic Factor and Neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321–334 (1994).
Conner, J. & Lauter, J. C. Distribution of Brain-Derived Neurotrophic Factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17, 2295–2313 (1997).
Numan, S. & Seroogy, K. B. Increased expression of TrkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway. Eur. J. Neurosci. 9, 489–495 (1997).
Korte, M. et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl Acad. Sci. USA 92, 8856–8860 (1995).
Ernfors, P., Lee, K.-F. & Jaenisch, R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147–150 (1994).
Cabelli, R. J., Shelton, D. L., Segal, R. A. & Shatz, C. J. Blockade of endogenous ligands of TrkB inhibits formation of ocular dominance columns. Neuron 19, 63–76 (1997).
Berendse, H. W., Galis-de-Graaf, Y. & Groenewegen, H. J. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. Comp. Neurol. 316, 314–347 (1992).
Huang, Q. et al. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and post-synaptic localization, and prevalence in the basal ganglia, limbic system and thalamic reticular nucleus. Proc. Natl Acad. Sci. USA 89, 11988–11992 (1992).
Cole, D. G., Kobierski, L. A., Konradi, C. & Hyman, S. E. 6-hydroxydopamine lesions of the rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl Acad. Sci. USA 91, 9631–9635 (1994).
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J. & Greenberg, M. E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726 (1998).
Shieh, P. B., Hu, S. C., Bobb, K., Timmusk, T. & Ghosh, A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727–740 (1998).
Flores, G., Barbeau, D., Quirion, R. & Srivastava, L. K. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J. Neurosci. 16, 2020–2026 (1996).
Whitelaw, R. B., Markou, A., Robbins, T. W. & Everitt, B. J. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 127, 213–224 (1996).
O'Brien, C. P., Childress, A. R., McMellan, A. T. & Ehrman, R. A. A learning model of addiction. Res. Publ. Assoc. Res. Nervous Mental Dis. 70, 157–177 (1992).
Horger, B. A. et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 4110–4122 (1999).
Carlsson, A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1, 179–186 (1988).
Diaz, J. et al. Phenotypical characterization of neurons expressing the dopamine D3 receptor. Neuroscience 65, 731–745 (1995).
Acknowledgements
We thank V. Mignon for technical assistance and C. Degott for providing the anti-IgG antibody. O.G. received grants from Fondation pour la Recherche Médicale and Lundbeck Foundation. This work was supported by grants from the European Commission (Fifth Framework Programme) and the National Institute on Drug Abuse to P.S.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guillin, O., Diaz, J., Carroll, P. et al. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 86–89 (2001). https://doi.org/10.1038/35075076
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35075076
This article is cited by
-
Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson’s disease model
BMC Pharmacology and Toxicology (2023)
-
The laterodorsal tegmentum-ventral tegmental area circuit controls depression-like behaviors by activating ErbB4 in DA neurons
Molecular Psychiatry (2023)
-
Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease
Metabolic Brain Disease (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.